Robust Inclusion Complex of Topotecan Comprised within a Rhodamine-Labeled β-Cyclodextrin: Competing Proton and

Maria Rosaria Di Nunzio1, Abderrazzak Douhal1

  • 1Departamento de Química Física, Facultad de Ciencias Ambientales y Bioquímica and INAMOL, Universidad de Castilla-La Mancha, Av. Carlos III, s/n, 45071 Toledo, Spain.

Pharmaceutics
|June 28, 2023
PubMed

Insights

Researchers studied how the anticancer drug topotecan (TPT) interacts with a fluorescently labeled cyclodextrin. They found a stable complex forms, and energy transfer occurs, enabling real-time tracking for drug delivery monitoring.

Area of Science:

  • Supramolecular Chemistry
  • Biophysical Chemistry
  • Materials Science

Background:

  • Monitoring drug delivery in cancer cells is crucial.
  • Rhodamine-based probes offer real-time tracking due to high fluorescence.
  • Functionalized cyclodextrins are promising for drug delivery systems.

Purpose of the Study:

  • To investigate the spectroscopic and photodynamic interactions between topotecan (TPT) and a rhodamine-labeled methylated β-cyclodextrin (RB-RM-βCD).
  • To understand the dynamics of TPT within the cyclodextrin host-guest system.
  • To explore the potential for FRET-based drug delivery monitoring.

Main Methods:

  • Steady-state and time-resolved spectroscopy.
  • Fluorescence spectroscopy to analyze drug-cyclodextrin interactions.
  • Complexation studies to determine stoichiometry and binding constants.

Main Results:

  • A stable 1:1 complex between TPT and RB-RM-βCD was formed with a binding constant (Keq) of ~4 × 10^4 M^-1.
  • Fluorescence quenching of TPT was observed due to cyclodextrin confinement and Förster Resonance Energy Transfer (FRET).
  • FRET occurred with ~40% efficiency over ~43 ps, indicating efficient energy transfer from TPT to the rhodamine probe.

Conclusions:

  • The study elucidates the photophysical interactions between TPT and RB-RM-βCD.
  • The observed FRET process provides a mechanism for real-time monitoring of drug encapsulation and release.
  • Findings support the development of novel fluorescent cyclodextrin-based nanosystems for bioimaging and drug delivery applications.

Related Concept Videos